Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Metabolic Disease and Lipodystrophy Models Tesamorelins FDA-approved indication for HIV lipodystrophy provides a well-characterized research foundation
Growing clinical acceptance of GLP-1 drugs boosts the segment growth
The list of FDA-approved indications for this class of medication has grown as of late (and currently includes type 2 diabetes, obesity, cardiovascular event risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease), and areas of interest for potential future indications are just as long and farreaching
Cold Spring Harb
doi: 10.23937/2378-3656/1410281 97 DesaiAPetrovJHashashJGPatelHBrahmbhattBKochharGSet al
US$ 26.99
US$ 21.23
US$ 29.80
US$ 27.05
US$ 28.94
US$ 29.42
US$ 23.55
US$ 28.32
